DDR genes analysis and PARP-inhibitors therapy as tailored management in metastatic prostate cancer: achieved answers, open questions and future perspectives.

Minerva urology and nephrology(2022)

引用 1|浏览5
暂无评分
摘要
article: DDR genes analysis and PARP-inhibitors therapy as tailored management in metastatic prostate cancer: achieved answers, open questions and future perspectives - Minerva Urology and Nephrology 2022 December;74(6):649-52 - Minerva Medica - Journals
更多
查看译文
关键词
metastatic prostate cancer,prostate cancer,parp-inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要